arrow
G

Gisele Nishiguchi

st jude childrens research hospital
H指数:19
被引数:1,987

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Direct-to-Biology Enabled Molecular Glue Discovery
2025-12-010
PRE
Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics

利用高通量蛋白质组学对cereblon新底物景观的无偏映射

2025-08-200
OAAI
Structure-Activity Relationship of Potent, Selective, and Orally Bioavailable Molecular Glue Degraders of CK1α

CK1α 的有效,选择性和口服生物利用度分子胶降解剂的构效关系

2024-09-121
PRE
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines
2024-01-169
OAAI
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

苯基戊二酰亚胺: 用于PROTACs设计的替代cerebon粘合剂

2021-11-1678
OA
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators
2021-05-2763
OAAI
Design and Discovery of N-(3-(2-(2-Hydroxyethoxy)-6morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the Clinic
2019-05-0632
OAAI
Simultaneous inhibition of SHP2 phosphatase at two allosteric sites
2018-07-011
PRE
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
2018-03-1430
OAAI
Dual Allosteric Inhibition of SHP2 Phosphatase
2018-01-05110
OAAI
Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers
2017-06-0846
PREAI
Development of a highly selective B/CRAF kinase inhibitor that exhibits antitumor activities in RAS and BRAF mutant tumors with minimal paradoxical activation
2016-07-150
PRE